Netarsudil/Latanoprost Fixed-Dose Combination for Elevated Intraocular Pressure (MERCURY)


November 1, 2019

Clinical trial

Netarsudil/Latanoprost Fixed-Dose Combination for Elevated Intraocular Pressure: Three-Month Data from a Randomized Phase 3 Trial.

Asrani S, Robin AL, Serle JB, Lewis RA, Usner DW, Kopczynski CC, Heah T.

Am J Ophthalmol. 2019 Nov;207:248-257.
Full text | Metrics.

September 1, 2019

Clinical trial

Once-Daily Netarsudil/Latanoprost Fixed-Dose Combination for Elevated Intraocular Pressure in the Randomized Phase 3 MERCURY-2 Study.

Walters TR, Ahmed IIK, Lewis RA, Usner DW, Lopez J, Kopczynski CC, Heah T.

Ophthalmol Glaucoma. 2019 Sep-Oct;2(5):280-289.
Full text | Metrics.

Share This Article :

Updated on March 7th, 2022

Source Archive